Provectus Biopharmaceuticals Inc (PVCT)
0.1948
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
Provectus Biopharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2006 | 35.71% |
| September 30, 2006 | 36.13% |
| June 30, 2006 | 36.04% |
| March 31, 2006 | 36.01% |
| December 31, 2005 | 36.03% |
| September 30, 2005 | 35.92% |
| Date | Value |
|---|---|
| June 30, 2005 | 36.06% |
| March 31, 2005 | 54.41% |
| December 31, 2004 | 44.08% |
| September 30, 2004 | 36.01% |
| June 30, 2004 | 36.05% |
| March 31, 2004 | 92.38% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Insmed Inc | 77.96% |
| NeuroMetrix Inc | 64.35% |
| Intra-Cellular Therapies Inc | 91.86% |
| Rhythm Pharmaceuticals Inc | 86.66% |
| Amylyx Pharmaceuticals Inc | 91.37% |